about
Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver modelRadiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor modelDynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysisDifferentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model.Emergent ultrasound interventions.Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation sizeInterventional CT: 30 years' experience.Tissue-based research in kidney cancer: current challenges and future directions.ALPHA glycolytic vasculogenesis better correlates with MRI and CT imaging techniques than the traditional oxygen vasculogenesis theory.Radiofrequency ablation: post-ablation assessment using CT perfusion with pharmacological modulation in a rat subcutaneous tumor model.Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model.Injectable polymer depot combined with radiofrequency ablation for treatment of experimental carcinoma in rat.Pneumodissection: an alternative protective technique for the percutaneous cryoablation of small renal masses.Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography.Efficiency of combined blocking of aerobic and glycolytic metabolism pathways in treatment of N1-S1 hepatocellular carcinoma in a rat model.Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits.Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes.A feasibility study of high intensity focused ultrasound for liver biopsy hemostasis.Computed Tomography-guided Drainage of Intra-abdominal Infections.
P50
Q30275368-6a27fa8e-4880-6270-c834-3424dcf446d6Q30409419-5d859772-4d2a-edce-ecfd-a79d5af0631aQ30454116-77ba8860-4b90-864c-62a3-be06debfa991Q30469210-1ebafb02-4640-5d98-faf7-32f330ca3833Q35760144-573d3ddc-471f-b837-bc40-34d145ecf012Q35769819-776947ba-44e7-89ab-54a0-e301f1838705Q35804140-6a1e4642-4573-188a-3c0d-0f93083cead4Q36397063-0d2bb088-4c93-c851-1fb0-782b63a2f503Q36982059-f0c04247-45da-a785-d34b-e170979f1771Q38270382-f7becfbd-46f2-abac-0557-2adecc23a6f0Q39886168-ded96d2f-4924-ccb6-f557-648e6231a136Q40007682-def928e4-4205-c970-6395-b6467c2f9841Q40209280-246cd797-4aa2-828b-311a-7a17e8fe588fQ43576095-b6cc046e-4a07-57f3-e82d-5aa30e2c39e6Q44185154-e23bbacc-4002-552b-f4f4-f7ddbbe1afb6Q45066372-64c5e4a8-4f9b-d587-c2f1-7f1612d5301bQ46764034-d39f5a54-48bd-45b5-d5ce-39a5e2bc0ef9Q48302100-1acf518f-46fa-3921-9d23-fdd839cdce22Q50250215-191c6e8f-4052-98c2-ca1b-8d39d52c7890Q54378432-e965a336-43df-d951-d3e1-294bc35ce25f
P50
name
John Haaga
@en
John Haaga
@es
John Haaga
@nl
type
label
John Haaga
@en
John Haaga
@es
John Haaga
@nl
altLabel
J. R. Haaga
@en
John R. Haaga
@en
John Robert Haaga
@en
prefLabel
John Haaga
@en
John Haaga
@es
John Haaga
@nl
P1006
P1015
P214
P227
P244
P269
P648
P1006
P1015
P1207
n2007135422
P1273
P1580
P2038
John_Haaga
P21
P213
0000 0001 1746 4395